Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology
Marta Stolarczyk, Bob J. Scholte
Mediators of Inflammation (2018) Vol. 2018, pp. 1-22
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
Matteo Calligaris, Doretta Cuffaro, Simone Bonelli, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 944-944
Open Access | Times Cited: 85
Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration
Mingyao Wang, Zhe Zhang, Jiangfeng Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 55
Alpha‐1‐antitrypsin: A possible host protective factor against Covid‐19
Mariana Braccialli de Loyola, Thaís Tereza Aguiar dos Reis, Guilherme Xavier Lyra Malcher de Oliveira, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 2
Open Access | Times Cited: 56
Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation
Hong Guo-Parke, Dermot Linden, Sinéad Weldon, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 49
New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways
Brianna Atto, Mathew Suji Eapen, Pawan Sharma, et al.
Clinical Science (2019) Vol. 133, Iss. 14, pp. 1663-1703
Open Access | Times Cited: 44
CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells
Mieke Veltman, Juan Bautista De Sanctis, Marta Stolarczyk, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 38
Immunomodulatory role of metalloproteinase ADAM17 in tumor development
Kai Wang, Zixue Xuan, Xiaoyan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Oxidative stress and abnormal bioactive lipids in early cystic fibrosis lung disease
Bob J. Scholte, Hamed Horati, Mieke Veltman, et al.
Journal of Cystic Fibrosis (2019) Vol. 18, Iss. 6, pp. 781-789
Open Access | Times Cited: 36
Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension
Jonathan Florentin, Jingsi Zhao, Yi‐Yin Tai, et al.
Life Science Alliance (2022) Vol. 5, Iss. 11, pp. e202101264-e202101264
Open Access | Times Cited: 20
The developmental and inflammatory disease target protein ADAM17 is vulnerable to off-target interaction by the drug eltrombopag: Insights from molecular modeling
Shahid Puthiyottil, Deepthi Jose, Nishamol Kuriakose, et al.
Computers in Biology and Medicine (2025) Vol. 186, pp. 109693-109693
Closed Access
Human Cellular Models for the Investigation of Lung Inflammation and Mucus Production in Cystic Fibrosis
Stefano Castellani, Sante Di Gioia, L. di Toma, et al.
Analytical Cellular Pathology (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 34
Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis
Massimo Conese, Sante Di Gioia
Pathophysiology (2021) Vol. 28, Iss. 1, pp. 155-188
Open Access | Times Cited: 21
Abnormal ADAM17 expression causes airway fibrosis in chronic obstructive asthma
Jing-Yun Chen, Wun-Hao Cheng, Kang‐Yun Lee, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111701-111701
Open Access | Times Cited: 21
Towards a Unified Approach in Autoimmune Fibrotic Signalling Pathways
Margherita Sisto, Sabrina Lisi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9060-9060
Open Access | Times Cited: 8
Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes
Jennifer Matthews, Sofia Villescas, Lakshini Y. Herat, et al.
Bioscience Reports (2021) Vol. 41, Iss. 5
Open Access | Times Cited: 19
The Downregulation of ADAM17 Exerts Protective Effects against Cardiac Fibrosis by Regulating Endoplasmic Reticulum Stress and Mitophagy
Chang Guan, Haifeng Zhang, Yajing Wang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 18
Novel biomarker genes which distinguish between smokers and chronic obstructive pulmonary disease patients with machine learning approach
Kazushi Matsumura, Shigeaki Ito
BMC Pulmonary Medicine (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 19
SARS- CoV-2 infection and oxidative stress in early-onset preeclampsia
Reinaldo Marı́n, Flor H. Pujol, Deliana Rojas, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 3, pp. 166321-166321
Open Access | Times Cited: 16
Targeting the EGFR‐ERK axis using the compatible solute ectoine to stabilize CFTR mutant F508del
Jack Wellmerling, Rachael E. Rayner, Sheng‐Wei Chang, et al.
The FASEB Journal (2022) Vol. 36, Iss. 5
Open Access | Times Cited: 9
Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease
Camilla Margaroli, Hamed Horati, Luke W. Garratt, et al.
Journal of Cystic Fibrosis (2022) Vol. 21, Iss. 6, pp. 967-976
Open Access | Times Cited: 9
Metalloprotease-Dependent S2′-Activation Promotes Cell–Cell Fusion and Syncytiation of SARS-CoV-2
James V. Harte, Samantha L. Wakerlin, Andrew J. Lindsay, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2094-2094
Open Access | Times Cited: 9
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17
Jiayue He, Shuguang Liu, Qi Tan, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 9044-9044
Open Access | Times Cited: 9
Antiviral properties of placental growth factors: A novel therapeutic approach for COVID-19 treatment
Meghnad G. Joshi, Jeevitaa Kshersagar, Shashikant Desai, et al.
Placenta (2020) Vol. 99, pp. 117-130
Open Access | Times Cited: 12
Viral replication of SARS-CoV-2 could be self-limitative – The role of the renin-angiotensin system on COVID-19 pathophysiology
Vinícius Novaes Rocha
Medical Hypotheses (2020) Vol. 145, pp. 110330-110330
Open Access | Times Cited: 11
Polarization of ADAM17‐driven EGFR signalling in electric field‐guided collective migration of epidermal sheets
Naixin Jia, Jie Liu, Guoqin Zhu, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 23, pp. 14073-14085
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top